{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:52:29Z","timestamp":1789426349031,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022811","name":"Fondazione Nadia Valsecchi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.dld.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:30:09Z","timestamp":1777116609000},"page":"1007-1015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (AISP)"],"prefix":"10.1016","volume":"58","author":[{"given":"Silvia","family":"Carrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3979-9553","authenticated-orcid":false,"given":"Livia","family":"Archibugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3922-1148","authenticated-orcid":false,"given":"Maria","family":"Terrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7924-5577","authenticated-orcid":false,"given":"Erica","family":"Secchettin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9337-0769","authenticated-orcid":false,"given":"Raffaele","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-8618","authenticated-orcid":false,"given":"Salvatore","family":"Paiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.dld.2026.04.007_bib0002","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MOG.0000000000000770","article-title":"Early detection of pancreatic cancer: current state and future opportunities","volume":"37","author":"Trikudanathan","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.dld.2026.04.007_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2025.102905","article-title":"Cancer incidence and mortality in Italy, 2013\u20132017","volume":"99","author":"Tittarelli","year":"2025","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12029-025-01184-1","article-title":"Current approaches of pancreatic cancer surveillance in high-risk individuals","volume":"56","author":"Heller","year":"2025","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.dld.2026.04.007_bib0005","doi-asserted-by":"crossref","unstructured":"Signoretti M, Bruno MJ, Zerboni G, Poley JW, Fave GD, Capurso G. Results of surveillance in individuals at high-risk of pancreatic cancer: A systematic review and meta-analysis. United European Gastroenterol J. 2018 Jan;6(4):489\u201399. doi:10.1177\/2050640617752182","DOI":"10.1177\/2050640617752182"},{"issue":"5","key":"10.1016\/j.dld.2026.04.007_bib0006","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","article-title":"Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention","volume":"164","author":"Stoffel","year":"2023","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.dld.2026.04.007_bib0007","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1053\/j.gastro.2023.02.032","article-title":"Surveillance for pancreatic cancer in high-risk individuals leads to improved outcomes: A propensity score-matched analysis","volume":"164","author":"Klatte","year":"2023","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.dld.2026.04.007_bib0008","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1542-3565(04)00244-7","article-title":"Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach","volume":"2","author":"Canto","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.dld.2026.04.007_bib0009","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/jamaoncol.2024.1930","article-title":"Pancreatic cancer surveillance and survival of high-risk individuals","volume":"10","author":"Blackford","year":"2024","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer","volume":"62","author":"Canto","year":"2013","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS)","volume":"69","author":"Goggins","year":"2020","journal-title":"Consort Gut"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.6004\/jnccn.2023.7097","article-title":"The pancreatic cancer early detection (PRECEDE) study is a global effort to drive early detection: baseline imaging findings in high-risk individuals","volume":"22","author":"Zogopoulos","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.dld.2026.04.007_bib0013","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/gutjnl-2020-323611","article-title":"Long-term yield of pancreatic cancer surveillance in high-risk individuals","volume":"71","author":"Overbeek","year":"2022","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.dld.2026.04.007_bib0014","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.dld.2010.04.016","article-title":"Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry","volume":"42","author":"Del Chiaro","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2026.04.007_bib0015","doi-asserted-by":"crossref","unstructured":"Capurso G, Paiella S, Carrara S, Butturini G, Secchettin E, Frulloni L, et al. Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group. Dig Liver Dis. 2020 Oct;52(10):1126\u201330. doi:10.1016\/j.dld.2020.07.027","DOI":"10.1016\/j.dld.2020.07.027"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0016","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41395-018-0414-z","article-title":"Results of first-round of surveillance in individuals at high-risk of pancreatic cancer from the AISP (Italian Association for the Study of the Pancreas) registry","volume":"114","author":"Paiella","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0017","doi-asserted-by":"crossref","first-page":"739","DOI":"10.14309\/ajg.0000000000002546","article-title":"Outcomes of a 3-year prospective surveillance in individuals at high risk of pancreatic cancer","volume":"119","author":"Paiella","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10689-024-00366-3","article-title":"The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals","volume":"23","author":"Archibugi","year":"2024","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/ueg2.70187","article-title":"Discovering hereditary risk through surveillance: a prospective genetic analysis of individuals with familial pancreatic cancer","volume":"14","author":"Paiella","year":"2026","journal-title":"United Eur Gastroenterol J"},{"issue":"10","key":"10.1016\/j.dld.2026.04.007_bib0020","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN Guidelines\u00ae insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024","volume":"21","author":"Daly","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.dld.2026.04.007_bib0021","unstructured":"Whitcomb DC. PRSS1-Related hereditary pancreatitis. 1993. PubMed PMID: 22379635."},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0022","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG Clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2026.04.007_bib0023","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/cancers15061852","article-title":"Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer or suspected related hereditary syndromes: historical prospective analysis","volume":"15","author":"Dal Buono","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.dld.2026.04.007_bib0024","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.annonc.2022.09.159","article-title":"Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2 and high-risk, early breast cancer","volume":"33","author":"Geyer","year":"2022","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance Olaparib for Germline BRCA -mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.dld.2026.04.007_bib0026","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1200\/JCO.2006.09.2452","article-title":"PancPRO: risk assessment for individuals with a Family history of pancreatic cancer","volume":"25","author":"Wang","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0027","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1053\/j.gastro.2010.08.012","article-title":"Hereditary pancreatic cancer","volume":"139","author":"Grover","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.dld.2026.04.007_bib0028","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0029","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies","volume":"44","author":"Maisonneuve","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/annonc\/mdr120","article-title":"Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case\u2013Control Consortium (PanC4)","volume":"23","author":"Lucenteforte","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0031","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","article-title":"Tobacco and the risk of pancreatic cancer: a review and meta-analysis","volume":"393","author":"Iodice","year":"2008","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"10.1016\/j.dld.2026.04.007_bib0032","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.286.8.921","article-title":"Physical activity, obesity, height, and the risk of pancreatic cancer","volume":"286","author":"Michaud","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0033","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3945\/ajcn.113.058123","article-title":"Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort","volume":"98","author":"Stolzenberg-Solomon","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.dld.2026.04.007_bib0034","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/gepi.21644","article-title":"Unidentified genetic variants influence pancreatic cancer risk: an analysis of polygenic susceptibility in the <scp>P<\/scp>an <scp>S<\/scp>can study","volume":"36","author":"Pierce","year":"2012","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.dld.2026.04.007_bib0035","doi-asserted-by":"crossref","unstructured":"Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer: table 1. Gut. 2007 Oct;56(10):1460\u20139. doi:10.1136\/gut.2006.108456","DOI":"10.1136\/gut.2006.108456"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0036","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cncr.35052","article-title":"The benefit of pancreatic cancer surveillance in carriers of germline BRCA1\/2 pathogenic variants","volume":"130","author":"Laish","year":"2024","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.dld.2026.04.007_bib0037","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MPA.0000000000002104","article-title":"Association between Family history and risk of pancreatic cancer in patients with BRCA1 and BRCA2 pathogenic variants","volume":"51","author":"Shah","year":"2022","journal-title":"Pancreas"},{"issue":"23","key":"10.1016\/j.dld.2026.04.007_bib0038","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0039","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JCO.18.01489","article-title":"Evaluating susceptibility to pancreatic cancer: ASCO provisional clinical opinion","volume":"37","author":"Stoffel","year":"2019","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.dld.2026.04.007_bib0040","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.21.02112","article-title":"Cancer risks associated with BRCA1 and BRCA2 pathogenic variants","volume":"40","author":"Li","year":"2022","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.dld.2026.04.007_bib0041","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.gie.2021.12.001","article-title":"ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations","volume":"95","author":"Sawhney","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0042","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1940-6207.CAPR-20-0448","article-title":"Germline pathogenic variants in the Ataxia Telangiectasia mutated (ATM) gene are associated with high and moderate risks for multiple cancers","volume":"14","author":"Hall","year":"2021","journal-title":"Cancer Prev Res"},{"issue":"11","key":"10.1016\/j.dld.2026.04.007_bib0043","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jamaoncol.2021.3701","article-title":"Risk of pancreatic cancer among individuals with pathogenic variants in the ATM gene","volume":"7","author":"Hsu","year":"2021","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0044","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of neoplastic progression in individuals at high Risk for pancreatic cancer undergoing long-term surveillance","volume":"155","author":"Canto","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ije\/dyx269","article-title":"Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives","volume":"47","author":"Molina-Montes","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0046","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jnci\/djx272","article-title":"Risk of different cancers among first-degree relatives of pancreatic cancer patients: influence of probands\u2019 Susceptibility gene mutation status","volume":"111","author":"Antwi","year":"2019","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0047","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10689-008-9214-8","article-title":"Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis","volume":"8","author":"Permuth-Wey","year":"2009","journal-title":"Fam Cancer"},{"issue":"17","key":"10.1016\/j.dld.2026.04.007_bib0048","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1200\/JCO.2015.64.0730","article-title":"Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers","volume":"34","author":"Vasen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.dld.2026.04.007_bib0049","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.18.01512","article-title":"Deleterious germline mutations are a risk factor for neoplastic progression among high-risk individuals undergoing pancreatic surveillance","volume":"37","author":"Abe","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10689-010-9414-x","article-title":"German national case collection for familial pancreatic cancer (FaPaCa): ten years experience","volume":"10","author":"Schneider","year":"2011","journal-title":"Fam Cancer"},{"issue":"14","key":"10.1016\/j.dld.2026.04.007_bib0051","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ejca.2015.07.004","article-title":"PanGen-Fam: Spanish registry of hereditary pancreatic cancer","volume":"51","author":"Mocci","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2026.04.007_bib0052","doi-asserted-by":"crossref","unstructured":"Earl J, Galindo-Pumari\u00f1o C, Encinas J, Barreto E, Castillo ME, Pach\u00f3n V, et al. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. EBioMedicine. 2020 Mar;53:102675. doi:10.1016\/j.ebiom.2020.102675","DOI":"10.1016\/j.ebiom.2020.102675"},{"key":"10.1016\/j.dld.2026.04.007_bib0053","doi-asserted-by":"crossref","unstructured":"Maurer E, Lehman B, Matth\u00e4i E, Denzer U, Figiel J, Jesinghaus M, et al. Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant-negative familial pancreatic cancer families. United European Gastroenterol J. 2024 Nov 19;12(9):1211\u201321. doi:10.1002\/ueg2.12631","DOI":"10.1002\/ueg2.12631"},{"issue":"8","key":"10.1016\/j.dld.2026.04.007_bib0054","doi-asserted-by":"crossref","DOI":"10.1200\/PO.24.00101","article-title":"Germline pathogenic variants in patients with pancreatic and periampullary cancers","author":"Ando","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41395-018-0395-y","article-title":"Identification of cystic lesions by secondary screening of familial pancreatic cancer (FPC) kindreds is not associated with the stratified risk of cancer","volume":"114","author":"Sheel","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0056","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10689-024-00388-x","article-title":"The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer","volume":"23","author":"Earl","year":"2024","journal-title":"Fam Cancer"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0057","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.gastro.2012.01.005","article-title":"Frequent detection of pancreatic lesions in asymptomatic high-risk individuals","volume":"142","author":"Canto","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0058","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jmri.27148","article-title":"MRI of the Pancreas","volume":"53","author":"Harrington","year":"2021","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0059","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.mric.2007.06.005","article-title":"MR imaging of the pancreas: 1.5T versus 3T","volume":"15","author":"Edelman","year":"2007","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.dld.2026.04.007_bib0060","doi-asserted-by":"crossref","unstructured":"Onishi H, Kim T, Hori M, Murakami T, Tatsumi M, Nakaya Y, et al. MR Cholangiopancreatography at 3.0 T Invest radiol. 2009 Sep;44(9):559\u201365. doi:10.1097\/RLI.0b013e3181b4c0ae","DOI":"10.1097\/RLI.0b013e3181b4c0ae"},{"key":"10.1016\/j.dld.2026.04.007_bib0061","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejrad.2017.04.009","article-title":"Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy","volume":"92","author":"Toft","year":"2017","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0062","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2018.11.014","article-title":"Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals","volume":"19","author":"Zerboni","year":"2019","journal-title":"Pancreatology"},{"issue":"9","key":"10.1016\/j.dld.2026.04.007_bib0063","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/gutjnl-2014-308008","article-title":"A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals","volume":"65","author":"Harinck","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0064","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.gie.2018.08.029","article-title":"Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma","volume":"89","author":"Thiruvengadam","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"10.1016\/j.dld.2026.04.007_bib0065","first-page":"1067","article-title":"Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer","volume":"30","author":"Brune","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.dld.2026.04.007_bib0066","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.gie.2019.01.030","article-title":"Setting minimum standards for training in EUS and ERCP: results from a prospective multicenter study evaluating learning curves and competence among advanced endoscopy trainees","volume":"89","author":"Wani","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0067","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gie.2006.09.018","article-title":"Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds","volume":"66","author":"Topazian","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2026.04.007_bib0068","doi-asserted-by":"crossref","unstructured":"Yamamiya A, Irisawa A, Kashima K, Kunogi Y, Nagashima K, Minaguchi T, et al. Interobserver reliability of endoscopic ultrasonography: Literature Review. Diagnostics. 2020 Nov 15;10(11):953. doi:10.3390\/diagnostics10110953","DOI":"10.3390\/diagnostics10110953"},{"key":"10.1016\/j.dld.2026.04.007_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112119","article-title":"Conditions at risk of pancreatic cancer: the radiology perspective","volume":"188","author":"Cannella","year":"2025","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10689-024-00394-z","article-title":"Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions","volume":"23","author":"Boekestijn","year":"2024","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0071","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00330-016-4377-4","article-title":"Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol","volume":"27","author":"Pozzi-Mucelli","year":"2017","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0072","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/diagnostics9010002","article-title":"The role of transabdominal ultrasound in the diagnosis of early stage pancreatic cancer: review and single-center experience","volume":"9","author":"Ashida","year":"2018","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0073","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000002312","article-title":"Pancreatic cysts greater than 1 cm are associated with an increased risk for developing Pancreatic cancer in individuals from Pancreatic-cancer prone kindreds undergoing surveillance","volume":"53","author":"Aijazi","year":"2024","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0074","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MPA.0000000000000725","article-title":"Prevalence and progression of pancreatic cystic precursor lesions differ between groups at high risk of developing pancreatic cancer","volume":"46","author":"Konings","year":"2017","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cgh.2023.03.035","article-title":"Intraductal papillary mucinous neoplasms in high-risk individuals: incidence, growth rate, and malignancy risk","volume":"22","author":"Overbeek","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0076","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas","volume":"24","author":"Ohtsuka","year":"2024","journal-title":"Pancreatology"},{"key":"10.1016\/j.dld.2026.04.007_bib0077","doi-asserted-by":"crossref","unstructured":"O\u2019Brien DP, Sandanayake NS, Jenkinson C, Gentry-Maharaj A, Apostolidou S, Fourkala EO, et al. Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Clinical cancer research. 2015 Feb 1;21(3):622\u201331. doi:10.1158\/1078-0432.CCR-14-0365","DOI":"10.1158\/1078-0432.CCR-14-0365"},{"issue":"7","key":"10.1016\/j.dld.2026.04.007_bib0078","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1158\/1078-0432.CCR-15-0879","article-title":"Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus","volume":"22","author":"Jenkinson","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094928","article-title":"Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study","volume":"9","author":"Nolen","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0080","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2020.11.052","article-title":"Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection","volume":"160","author":"Fahrmann","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0081","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/cells13010003","article-title":"A comprehensive review of the potential role of liquid biopsy as a diagnostic, prognostic, and predictive biomarker in pancreatic ductal adenocarcinoma","volume":"13","author":"Stosic","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0082","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018581","article-title":"Diagnostic value of various liquid biopsy methods for pancreatic cancer","volume":"99","author":"Zhu","year":"2020","journal-title":"Med (Baltim)"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0083","article-title":"Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer","volume":"73","author":"Ben-Ami","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0084","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.gastro.2023.09.050","article-title":"A circulating panel of circRNA biomarkers for the noninvasive and early detection of pancreatic ductal adenocarcinoma","volume":"166","author":"Xu","year":"2024","journal-title":"Gastroenterology"},{"issue":"26","key":"10.1016\/j.dld.2026.04.007_bib0085","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.24.00287","article-title":"Development and validation of a cell-free DNA fragmentomics\u2013Based model for early detection of pancreatic cancer","volume":"43","author":"Yin","year":"2025","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.dld.2026.04.007_bib0086","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2468-1253(25)00056-1","article-title":"Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study","volume":"10","author":"Mahajan","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.04.007_bib0087","article-title":"Validation of a serum-based biomarker signature for detection of early-stage pancreatic ductal adenocarcinoma","author":"Lucas","year":"2025","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0088","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000468","article-title":"Detection of early-stage pancreatic ductal adenocarcinoma from blood samples: results of a multiplex biomarker signature validation study","volume":"13","author":"Brand","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2026.04.007_bib0089","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2019.01.039","article-title":"Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma","volume":"156","author":"Sah","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","article-title":"Pancreatic cancer\u2013Associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer","volume":"134","author":"Chari","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0091","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jnci\/djy090","article-title":"Pancreatic cancer following incident diabetes in African Americans and Latinos: the multiethnic cohort","volume":"111","author":"Setiawan","year":"2019","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0092","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0093","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2016.11.046","article-title":"A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes","volume":"152","author":"Boursi","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0094","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MPA.0000000000001209","article-title":"Performance of a Multidisciplinary pancreatic Cancer Conference in predicting and managing resectable pancreatic cancer","volume":"48","author":"Rao","year":"2019","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.hpb.2016.11.002","article-title":"Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study","volume":"19","author":"Brauer","year":"2017","journal-title":"HPB"},{"issue":"7","key":"10.1016\/j.dld.2026.04.007_bib0096","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.acra.2017.12.010","article-title":"Does second reader opinion affect patient management in pancreatic ductal adenocarcinoma?","volume":"25","author":"Corrias","year":"2018","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0097","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0300891621999092","article-title":"Impact of multidisciplinary approach and radiologic review on surgical outcome and overall survival of patients with pancreatic cancer: a retrospective cohort study","volume":"108","author":"Artioli","year":"2022","journal-title":"Tumori J"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0098","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.13131184","article-title":"Pancreatic Ductal adenocarcinoma radiology reporting template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association","volume":"270","author":"Al-Hawary","year":"2014","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.dld.2026.04.007_bib0099","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/bjs.11716","article-title":"Modelling centralization of pancreatic surgery in a nationwide analysis","volume":"107","author":"Balzano","year":"2020","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0100","article-title":"Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries","volume":"111","author":"Fusai","year":"2024","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0101","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.amjsurg.2021.03.030","article-title":"Identifying the optimal case-volume threshold for pancreatectomy in contemporary practice","volume":"223","author":"Jogerst","year":"2022","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/SLA.0000000000006094","article-title":"Surveillance of individuals at high risk of developing pancreatic cancer","volume":"279","author":"Paiella","year":"2024","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.dld.2026.04.007_bib0103","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/2050640620945534","article-title":"Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables","volume":"8","author":"Scholten","year":"2020","journal-title":"United Eur Gastroenterol J"},{"issue":"5","key":"10.1016\/j.dld.2026.04.007_bib0104","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/eurpub\/ckaf119","article-title":"Creating a data processing warehouse to support performance monitoring of cancer screening programmes in Europe using a common set of indicators","volume":"35","author":"Lucas","year":"2025","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.dld.2026.04.007_bib0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.puhe.2024.12.010","article-title":"Prioritizing performance and outcome indicators for quality assessment of cancer screening programs in the EU","volume":"239","author":"Sheridan","year":"2025","journal-title":"Public Health"},{"issue":"8","key":"10.1016\/j.dld.2026.04.007_bib0106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161187","article-title":"Integrated cancer screening performance indicators: a systematic review","volume":"11","author":"Mema","year":"2016","journal-title":"PLoS One"},{"issue":"28","key":"10.1016\/j.dld.2026.04.007_bib0107","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.22.00298","article-title":"The multicenter cancer of pancreas screening study: impact on stage and survival","volume":"40","author":"Dbouk","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.dld.2026.04.007_bib0108","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/pon.5370","article-title":"The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis","volume":"29","author":"Paiella","year":"2020","journal-title":"Psychooncology"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0109","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/cancers16010086","article-title":"Assessment of the psychosocial impact of pancreatic cancer surveillance in high-risk individuals","volume":"16","author":"Anez-Bruzual","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.dld.2026.04.007_bib0110","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3390\/cancers17183014","article-title":"Assessment of psychological burden in individuals with hereditary risk of pancreatic cancer under surveillance: evaluation of distress 3 years after enrollment","volume":"17","author":"Marinelli","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.dld.2026.04.007_bib0111","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10689-016-9930-4","article-title":"Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance","volume":"16","author":"Konings","year":"2017","journal-title":"Fam Cancer"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0112","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10689-024-00392-1","article-title":"Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer","volume":"23","author":"Wang","year":"2024","journal-title":"Fam Cancer"},{"issue":"4","key":"10.1016\/j.dld.2026.04.007_bib0113","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MPA.0000000000001268","article-title":"Cost-effectiveness of pancreatic cancer surveillance in high-risk individuals","volume":"48","author":"Corral","year":"2019","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.dld.2026.04.007_bib0114","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/MPA.0000000000001835","article-title":"Threshold analysis of the cost-effectiveness of endoscopic ultrasound in patients at high risk for pancreatic ductal adenocarcinoma","volume":"50","author":"Kumar","year":"2021","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.dld.2026.04.007_bib0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1200\/OP.23.00495","article-title":"Cost-effectiveness analysis of screening for pancreatic cancer among high-risk populations","volume":"20","author":"Peters","year":"2024","journal-title":"JCO Oncol Pr"},{"issue":"3","key":"10.1016\/j.dld.2026.04.007_bib0116","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10689-024-00392-1","article-title":"Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer","volume":"23","author":"Wang","year":"2024","journal-title":"Fam Cancer"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:26:31Z","timestamp":1784719591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826007024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":116,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1590865826007024"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.04.007","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (AISP)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}